The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Puumala Virus

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Puumala Virus

 

High impact information on Puumala Virus

  • Polymerase chain reaction detection of Puumala virus RNA in formaldehyde-fixed biopsy material [6].
  • To understand more about the molecular mechanisms that lead to these diseases, the associations of Puumala virus nucleocapsid protein (PUUV-N) with cellular proteins were studied by yeast two-hybrid screening [7].
  • Two monoclonal antibody escape virus mutants (MARs), rescued from a human MAb to glycoprotein 2 (G2) and a bank vole monoclonal antibody (MAb) directed to glycoprotein 1 (G1) of Puumala virus, strain Sotkamo, were produced by using a combination of neutralization tests and antigen detection [8].
  • Single amino acid substitutions in Puumala virus envelope glycoproteins G1 and G2 eliminate important neutralization epitopes [8].
  • Rodent antibody end-point titers to bac-TUL-N and to truncated N fragments indicated that the NH2-terminal region is the major antigenic target and revealed a high cross-reactivity to Puumala virus N [9].
 

Chemical compound and disease context of Puumala Virus

 

Biological context of Puumala Virus

  • In this study we examined the dynamic of PBL Fas and FasL expression, the first-step dead caspase-8, -2, -9 and effector caspase-3, -7 and -10 activity in freshly isolated PBL lysates, and anti-CD3-induced PBL mitogenic response and apoptosis in patients with Puumala virus (PUUV) associated hemorrhagic fever with the renal syndrome (HFRS) [13].
 

Gene context of Puumala Virus

  • Human sera from residents of various regions of Sweden were examined for antibody to Puumala virus, and the incidence of NE was determined [14].
  • Although the majority of anti-SNV positive sera cross-reacted with rN proteins of Puumala virus and Dobrava virus, the lacking reactivity of a few sera with these heterologous rN antigens in the corresponding IgM and IgG ELISAs demonstrates the value of virus-specific test formats for acute-phase sera [15].
  • Reverse transcriptase polymerase chain reaction cloning and sequencing were used to determine the range of S gene/N protein variability in wild Puumala virus (PUU) strains and to study phylogenetic relationships between two groups of strains which originated from Finland and from European Russia [16].
 

Analytical, diagnostic and therapeutic context of Puumala Virus

  • Sera from 1538 subjects (750 men, 788 women), 25-64 years of age, were analysed for the presence of Puumala virus (PUV) specific-IgG by the indirect immunofluorescence antibody test [17].
  • IgM and IgG ELISA to Puumala virus were evaluated using sera from patients with haemorrhagic fever with renal syndrome (HFRS) from different geographical regions: Sweden, Denmark, Norway, Belgium and the European USSR [18].

References

  1. Cross-neutralization of hantaviruses with immune sera from experimentally infected animals and from hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome patients. Chu, Y.K., Jennings, G., Schmaljohn, A., Elgh, F., Hjelle, B., Lee, H.W., Jenison, S., Ksiazek, T., Peters, C.J., Rollin, P. J. Infect. Dis. (1995) [Pubmed]
  2. Cloning and sequencing of Puumala virus Sotkamo strain S and M RNA segments: evidence for strain variation in hantaviruses and expression of the nucleocapsid protein. Vapalahti, O., Kallio-Kokko, H., Salonen, E.M., Brummer-Korvenkontio, M., Vaheri, A. J. Gen. Virol. (1992) [Pubmed]
  3. Baculovirus expression of a human G2-specific, neutralizing IgG monoclonal antibody to Puumala virus. Liang, M., Guttieri, M., Lundkvist, A., Schmaljohn, C. Virology (1997) [Pubmed]
  4. Epidemiological investigations following an outbreak of hemorrhagic fever with renal syndrome in Greece. LeDuc, J.W., Antoniades, A., Siamopoulos, K. Am. J. Trop. Med. Hyg. (1986) [Pubmed]
  5. Hypophyseal hemorrhage and panhypopituitarism during Puumala Virus Infection: Magnetic Resonance Imaging and detection of viral antigen in the hypophysis. Hautala, T., Sironen, T., Vapalahti, O., Pääkkö, E., Särkioja, T., Salmela, P.I., Vaheri, A., Plyusnin, A., Kauma, H. Clin. Infect. Dis. (2002) [Pubmed]
  6. Polymerase chain reaction detection of Puumala virus RNA in formaldehyde-fixed biopsy material. Heiske, A., Anheier, B., Pilaski, J., Klenk, H.D., Gröne, H.J., Feldmann, H. Kidney Int. (1999) [Pubmed]
  7. Hantavirus nucleocapsid protein interacts with the Fas-mediated apoptosis enhancer Daxx. Li, X.D., Mäkelä, T.P., Guo, D., Soliymani, R., Koistinen, V., Vapalahti, O., Vaheri, A., Lankinen, H. J. Gen. Virol. (2002) [Pubmed]
  8. Single amino acid substitutions in Puumala virus envelope glycoproteins G1 and G2 eliminate important neutralization epitopes. Hörling, J., Lundkvist, A. Virus Res. (1997) [Pubmed]
  9. Characterization of Tula virus antigenic determinants defined by monoclonal antibodies raised against baculovirus-expressed nucleocapsid protein. Lundkvist, A., Vapalahti, O., Plyusnin, A., Sjölander, K.B., Niklasson, B., Vaheri, A. Virus Res. (1996) [Pubmed]
  10. Increased production of nitric oxide in patients infected with the European variant of hantavirus. Groeneveld, P.H., Colson, P., Kwappenberg, K.M., Clement, J. Scand. J. Infect. Dis. (1995) [Pubmed]
  11. Anti-idiotypic antibodies against Puumala virus glycoprotein-specific monoclonal antibodies inhibit virus infection in cell cultures. Lundkvist, A., Scholander, C., Niklasson, B. Arch. Virol. (1993) [Pubmed]
  12. Fluorescein iris angiography in the febrile phase of Puumala virus infection (hemorrhagic fever with renal syndrome). Puustjärvi, T., Kontkanen, M., Repo, L., Lähdevirta, J., Mäntyjärvi, M. Acta ophthalmologica Scandinavica. (1998) [Pubmed]
  13. Lymphocyte Apoptosis during Hemorragic Fever with Renal Syndrome. Akhmatova, N.K., Yusupova, R.S., Khaiboullina, S.F., Sibiryak, S.V. Russ. J. Immunol. (2003) [Pubmed]
  14. Epidemiology of nephropathia epidemica in Sweden. Niklasson, B., LeDuc, J.W. J. Infect. Dis. (1987) [Pubmed]
  15. Development and evaluation of serological assays for detection of human hantavirus infections caused by Sin Nombre virus. Schmidt, J., Meisel, H., Hjelle, B., Krüger, D.H., Ulrich, R. J. Clin. Virol. (2005) [Pubmed]
  16. Genetic variation of wild Puumala viruses within the serotype, local rodent populations and individual animal. Plyusnin, A., Vapalahti, O., Lehväslaiho, H., Apekina, N., Mikhailova, T., Gavrilovskaya, I., Laakkonen, J., Niemimaa, J., Henttonen, H., Brummer-Korvenkontio, M. Virus Res. (1995) [Pubmed]
  17. Prevalence of serum IgG antibodies to Puumala virus (haemorrhagic fever with renal syndrome) in northern Sweden. Ahlm, C., Linderholm, M., Juto, P., Stegmayr, B., Settergren, B. Epidemiol. Infect. (1994) [Pubmed]
  18. Haemorrhagic fever with renal syndrome: evaluation of ELISA for detection of Puumala-virus-specific IgG and IgM. Niklasson, B., Tkachenko, E., Ivanov, A.P., van der Groen, G., Wiger, D., Andersen, H.K., LeDuc, J., Kjelsson, T., Nyström, K. Res. Virol. (1990) [Pubmed]
 
WikiGenes - Universities